What does MED.OPHTA do?

MED.OPHTA is registered with the CBE as active in: Handel in eigen onroerend goed. Private Limited, started on 19 February 1999, 1 establishment.

What is the address of MED.OPHTA?

The registered office of MED.OPHTA is located at Papenkasteelstraat 33, 1180 Ukkel.

Is MED.OPHTA still active?

Yes. According to the CBE (1 October 2026) MED.OPHTA is active, legal situation “Normale toestand”, started on 19 February 1999.

Is MED.OPHTA registered on Peppol?

No, MED.OPHTA is currently not registered on the Peppol network.

What is the enterprise number of MED.OPHTA?

The enterprise number of MED.OPHTA is BE0465485974.

When was MED.OPHTA founded?

MED.OPHTA was founded on 19 February 1999.

Who are the directors of MED.OPHTA?

According to the 2025 annual accounts, the directors of MED.OPHTA are: JEAN ASSAF.

Is MED.OPHTA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 February 1999; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MED.OPHTA make in 2025?

MED.OPHTA posted a profit after taxes of € 396,563 in financial year 2025.

What is the revenue of MED.OPHTA?

In its most recent annual accounts (2025), MED.OPHTA reported revenue of € 0.

MED.OPHTA (Private Limited) - Ukkel - BE0465485974

Dossier MED.OPHTA, printed on 1 October 2026 from databakkes.be/en/0465485974/med-ophta. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2025.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MED.OPHTA from Ukkel, company number BE0465485974, closed financial year 2025 with a result of € 396,563 after tax. For that financial year MED.OPHTA recorded revenue of € 0 and equity of € 959,997. Compared with financial year 2024, the result moved from € 352,525 to € 396,563. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 19, 2026.

What it is worth Growing

€ 959,997

▲ 44% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 396,563

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 540,208

▲ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 102,332 paid out

26 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 258,336

▼ 28% vs 2024

€ 100,001 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 1,039

▼ 92% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 10,350

▲ 61% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 72,258 Gross margin 2022: € 72,258 First fiscal year in the series	€ 72,309 Gross margin 2023: € 72,309 Unchanged (€ 72,258) Favourable step	€ 559,534 Gross margin 2024: € 559,534 ▲ € 487,225 vs 2023 (€ 72,309) Favourable step	€ 610,953 Gross margin 2025: € 610,953 ▲ 9% vs 2024 (€ 559,534) Favourable step	▲ 9%
Profit after taxes	€ -3,973 Profit after taxes 2022: € -3,973 First fiscal year in the series	€ -2,795 Profit after taxes 2023: € -2,795 ▲ € 1,178 vs 2022 (€ -3,973) Favourable step	€ 352,525 Profit after taxes 2024: € 352,525 ▲ € 355,320 vs 2023 (€ -2,795) Favourable step	€ 396,563 Profit after taxes 2025: € 396,563 ▲ 12% vs 2024 (€ 352,525) Favourable step	▲ 12%
Equity	€ 538,235 Equity 2022: € 538,235 First fiscal year in the series	€ 421,630 Equity 2023: € 421,630 ▼ 22% vs 2022 (€ 538,235) Unfavourable step	€ 665,765 Equity 2024: € 665,765 ▲ 58% vs 2023 (€ 421,630) Favourable step	€ 959,997 Equity 2025: € 959,997 ▲ 44% vs 2024 (€ 665,765) Favourable step	▲ 44%
Total debts	€ 844,511 Total debts 2022: € 844,511 First fiscal year in the series	€ 894,085 Total debts 2023: € 894,085 ▲ 6% vs 2022 (€ 844,511) Unfavourable step	€ 774,540 Total debts 2024: € 774,540 ▼ 13% vs 2023 (€ 894,085) Favourable step	€ 416,405 Total debts 2025: € 416,405 ▼ 46% vs 2024 (€ 774,540) Favourable step	▼ 46%
Cash	€ 36,993 Cash 2022: € 36,993 First fiscal year in the series	€ 5,136 Cash 2023: € 5,136 ▼ 86% vs 2022 (€ 36,993) Unfavourable step	€ 388,090 Cash 2024: € 388,090 ▲ € 382,955 vs 2023 (€ 5,136) Favourable step	€ 540,208 Cash 2025: € 540,208 ▲ 39% vs 2024 (€ 388,090) Favourable step	▲ 39%
Land & buildings	€ 1,311,432 Land & buildings 2022: € 1,311,432 First fiscal year in the series	€ 1,264,455 Land & buildings 2023: € 1,264,455 ▼ 4% vs 2022 (€ 1,311,432) Unchanged	€ 1,137,706 Land & buildings 2024: € 1,137,706 ▼ 10% vs 2023 (€ 1,264,455) Unchanged	€ 1,044,159 Land & buildings 2025: € 1,044,159 ▼ 8% vs 2024 (€ 1,137,706) Unchanged	▼ 8%
Retained profit	€ 531,517 Retained profit 2022: € 531,517 First fiscal year in the series	€ 414,913 Retained profit 2023: € 414,913 ▼ 22% vs 2022 (€ 531,517) Unfavourable step	€ 659,048 Retained profit 2024: € 659,048 ▲ 59% vs 2023 (€ 414,913) Favourable step	€ 953,279 Retained profit 2025: € 953,279 ▲ 45% vs 2024 (€ 659,048) Favourable step	▲ 45%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 113,810 Dividend 2023: € 113,810 Unchanged (€ 0) Unchanged	€ 108,390 Dividend 2024: € 108,390 ▼ 5% vs 2023 (€ 113,810) Unchanged	€ 102,332 Dividend 2025: € 102,332 ▼ 6% vs 2024 (€ 108,390) Unchanged	▼ 6%
Bank debt	€ 579,238 Bank debt 2022: € 579,238 First fiscal year in the series	€ 458,338 Bank debt 2023: € 458,338 ▼ 21% vs 2022 (€ 579,238) Favourable step	€ 358,337 Bank debt 2024: € 358,337 ▼ 22% vs 2023 (€ 458,338) Favourable step	€ 258,336 Bank debt 2025: € 258,336 ▼ 28% vs 2024 (€ 358,337) Favourable step	▼ 28%
Balance sheet total	€ 1,438,798 Balance sheet total 2022: € 1,438,798 First fiscal year in the series	€ 1,369,694 Balance sheet total 2023: € 1,369,694 ▼ 5% vs 2022 (€ 1,438,798) Unchanged	€ 1,610,883 Balance sheet total 2024: € 1,610,883 ▲ 18% vs 2023 (€ 1,369,694) Unchanged	€ 1,679,607 Balance sheet total 2025: € 1,679,607 ▲ 4% vs 2024 (€ 1,610,883) Unchanged	▲ 4%

Key figures of MED.OPHTA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MED.OPHTA?

What happened at MED.OPHTA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 19, 2026 Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
Feb 19, 1999 Start of the company according to the CBE. KBO
Feb 18, 1999 New establishment in Ukkel. KBO

In short

From € 3,973 loss in 2022 to € 396,563 profit in 2025.

Paid € 12,997 in corporate taxes since 2022.

Best year ever: 2025, with € 396,563 profit.

Paid out € 324,531 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at MED.OPHTA? We notify you, reason included.

Follow MED.OPHTA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

JEAN ASSAF

MED.OPHTA

MO ACTIVITIES

Behind MED.OPHTA is JEAN ASSAF. JEAN ASSAF is also behind MO ACTIVITIES.

See the full network in the app

Directors

According to the 2025 annual accounts

JEAN ASSAF

Director

Also active at: MO ACTIVITIES

Establishments

Establishment units

Physical locations of this company

Registered office

Papenkasteelstraat 33

1180 Ukkel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

MO ACTIVITIES same network

€ 0 revenue · 2025

OPHTAMED